Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 32 (6), 293-300

Comparison of Pharmacokinetics of Newly Discovered Aromatase Inhibitors by a Cassette Microdosing Approach in Healthy Japanese Subjects

Affiliations
Clinical Trial

Comparison of Pharmacokinetics of Newly Discovered Aromatase Inhibitors by a Cassette Microdosing Approach in Healthy Japanese Subjects

Hiroyuki Kusuhara et al. Drug Metab Pharmacokinet.

Abstract

The aim of the present study is to investigate the pharmacokinetics of our newly developed aromatase inhibitors (cetrozole and TMD-322) in healthy subjects by a cassette microdose strategy. A cocktail of cetrozole and TMD-322 was administered intravenously or orally (1.98 μg for each drug) to six healthy volunteers in a crossover fashion. Anastrozole (1.98 μg) was also included in the oral cocktail. Total body clearance and bioavailability were 12.1 ± 7.1 mL/min/kg and 34.9 ± 32.3% for cetrozole, and 16.8 ± 3.5 mL/min/kg and 18.4 ± 12.2% for TMD-322, respectively. The area under the plasma concentration-time curves of cetrozole and TMD-322 after oral administration was markedly lower than that of anastrozole because of their high hepatic clearance. Two subjects out of six exhibited 4- and 17-fold larger exposure of cetrozole than the others following intravenous and oral administration, respectively. Such variation was not observed for TMD-322 and anastrozole. Extensive metabolism of cetrozole and TMD-322 was observed in the CYP2C19 expression system among the test CYP isoforms (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4). We report the first clinical investigation of our aromatase inhibitors by a cassette microdose strategy in healthy Japanese subjects. This strategy offers an optional approach for candidate selection as a phase zero study in drug development.

Keywords: Aromatase inhibitor; Cassette dosing approach; First in human study; LC–MS/MS; Microdosing clinical trial; Pharmacokinetic properties.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

  • Predictive Value of Microdose Pharmacokinetics
    M van Nuland et al. Clin Pharmacokinet 58 (10), 1221-1236. PMID 31030372. - Review
    Phase 0 microdose trials are exploratory studies to early assess human pharmacokinetics of new chemical entities, while limiting drug exposure and risks for participants. …

MeSH terms

LinkOut - more resources

Feedback